Controlled Drug Release Articles & Analysis
9 news found
With Protheragen-ING’s microneedle technology, controlled drug delivery can be achieved using precise and efficient use of both hollow and solid structures made from any materials (silicons, metals or biodegradable polymers). ...
Oral thin films present a novel approach in drug delivery, offering ease in administration without the need for water and reducing risks associated with traditional dosage forms. ...
These hydrogels are pivotal in medical devices, regenerative medicine, drug delivery systems, 3D cell culture, and wound healing." Diverse Product Offering: Biopharma PEG’s multi-arm PEG products are available with various branching structures and functional groups to meet the specific needs of researchers and developers in the medical and bioorganic fields. ...
By utilizing a combination of cutting-edge analytical techniques, CD Formulation is able to analyze the drug release kinetics, bioavailability, and pharmacokinetics of oral thin films with unprecedented accuracy. ...
Transdermal patches, yet another key service area of CD Formulation, provide controlled drug release through the skin. They offer several advantages, including sustained drug delivery, improved patient compliance, and reduced side effects. ...
Microspheres are tiny spherical particles that allow for controlled drug release, ensuring a sustained therapeutic effect over an extended period of time. ...
Microspheres, tiny spherical particles typically ranging from 1 to 100 microns in diameter, offer immense potential for targeted drug delivery. By encapsulating active pharmaceutical ingredients (APIs) within these microspheres, drugs can be delivered directly to specific tissues or organs, resulting in improved therapeutic efficacy and reduced side effects. ...
“Our new collection of pharmaceutical excipients covers a wide range of dosage forms, including liquids, solids, semi-solids, controlled-release, transdermal, mucosal, and micro drug delivery systems. ...
Tenofovir is one of the most frequently used antiretroviral drugs in the multi-drug treatment of HIV infection. However, since tenofovir does not cross the BBB following systemic administration, the treatment is not effective against viral reservoirs in the central nervous system (CNS). ...